Navigation Links
Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
Date:9/27/2007

- E. coli O157:H7 vaccine named "best new veterinary product for livestock"

-

BELLEVILLE, ON, Sept. 27 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that its vaccine against E. coli O157:H7 in cattle has been recognized internationally as the best new veterinary product for livestock. The Company received the Animal Pharm industry excellence award at the Animal Pharm Awards '07 dinner this week in London, UK. Animal Pharm is a worldwide business-to-business news service for the animal health industries, published by Informa Healthcare, part of the Informa Group. The Animal Pharm newsletter has been published for more than 20 years and has more than 2,000 readers in animal health companies and related businesses around the world (http://www.animalpharmnews.com or http://www.animalpharmawards.com ).

The "best new veterinary product for livestock" award recognizes excellence in pharmaceutical or vaccine development for production animals. In this category, the 12-member panel of independent industry judges looks for the product that represents the greatest therapeutic, prophylactic, or production advance. The shortlist of nominees for this award included Merial SAS, Norbrook Laboratories Ltd. and Schering-Plough Animal Health.

"This international recognition of our E. coli O157:H7 vaccine provides external validation of its importance and sophistication by our peers in the animal health industry," said Graeme McRae, President & CEO of Bioniche Life Sciences Inc. "This made-in-Canada technology has taken seven years of development and many millions of dollars in investment. It represents the first vaccine for intervention against this dangerous bacterium and we are proud to provide this
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Alerts for safety of heart device
2. Surgery a safety in senility
3. Surgery a safety in senility
4. Surgery a safety in senility
5. New standards for Human Research Safety
6. Safety of soy under suspicion
7. The Safety Of Prenatal Ultrasounds Questioned
8. Report on the Safety and Effectiveness of Melatonin supplements
9. Monitoring Drug Safety
10. Testosterone patch for women Rejected For safety Reasons
11. Law ensuring safety and quality of Herbal drugs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... the H1N1 virus will come back during winter isn,t...ealthDay News) -- The number of states reporting w...this week -- to 25 from a high of 48 just two week...anwhile, the supply of H1N1 swine flu vaccine cont... of the U.S. Centers for Disease Control and Preve...
(Date:12/4/2009)...s more smoke inhaled through hookah, research show... Water pipes are no safer than cigarettes for smok...nd that people who smoke tobacco with a water pipe...hem at risk for heart disease and nicotine addicti... to 50, who smoked tobacco using a water pipe and ...
(Date:12/4/2009)...tudy found they spurred blood vessel growth after ...ay News) -- Adult stem cells appear to help repair...phase 1 study of 53 patients found that stem cells... blood vessels in heart tissue damaged by heart at...ections within 10 days of having a heart attack. D...
(Date:12/4/2009)... , MADISON, Wis., Dec. 4 /PRNewswire-FirstCall...fall, the Wisconsin Department of Health Services ... quickly than ever before. Join Sonic Foundry, In... for rich media webcasting and knowledge managemen... Wisconsin Department of Health Services, will sha...
(Date:12/4/2009)... , BOULDER, Colo., Dec. 4 ... ON LOVE ,, Kathryn Budig, a prominent yoga tea... to healing--with a viewing of Twilight,s New Moon...al.com: ,, http://www.elephantjournal.com/2009...urnal.com: TASHI KING AND BREAST CANCER ,, ele...
Breaking Medicine News(10 mins):Health News:Swine Flu Continues to Wane 2Health News:Water Pipes No Safer Than Cigarettes 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3
...End the Tobacco Settlement Spending Spree and Dire...TON, Nov. 19 This Sunday, November 23, 2008, will...he largest civil settlement in United States histo...for smoking-caused health care costs and imposed m...
...endations for System in Critical Need of Reform , ...ety policy, organization and communications were a...onella Saintpaul, according to a report released t...ssons to Be Learned from the 2008 Salmonella Saint...
...weight-loss surgery, known as bariatric surgery, a...e at lower risk for pregnancy-related diabetes and...iously affect the mother or her baby -- than pregn... JAMA. , , The findings are part of an evide...
...airman, Tony Strange Appointed to CEO position and..., MELVILLE, N.Y., Nov. 18 /PRNewswire-FirstCall/...V ), a leading provider of comprehensive home heal...ome the Company,s Chief Executive Officer in addit...
...ntract , , BUFFALO, N.Y., Nov. 18 Representa...ations joined Teamsters Local 375 today to show su... paramedics employed by Rural/Metro. , , The ...ear-round. The company and the Teamsters are retur...
...t reverse, prevent autoimmune disease , , ...nder drug that effectively treats leukemia and oth...ersity of California San Francisco, researchers r...tes is usually diagnosed in children and young adu...
Other Medicine News:Health News:November 23 Marks Tenth Anniversary of the Largest Civil Settlement in U.S. History 2Health News:November 23 Marks Tenth Anniversary of the Largest Civil Settlement in U.S. History 3Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 2Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 3Health News:Some Pregnancy-Related Complications Minimized for Women Who Have Had Weight-Loss Surgery 2Health News:Some Pregnancy-Related Complications Minimized for Women Who Have Had Weight-Loss Surgery 3Health News:Gentiva Health Services Confirms Management Succession 2Health News:Gentiva Health Services Confirms Management Succession 3Health News:Gentiva Health Services Confirms Management Succession 4Health News:Community, Labor Organizations Rally for Buffalo EMTs, Paramedics 2Health News:Cancer Drugs May Treat Type 1 Diabetes 2
(Date:12/4/2009)...c. 4 Suneva Medical, a privately-h...ced the appointment of Philip Ranker as Vice Presi...r. Ranker will lead all Suneva Medical,s general a...ounting, IT, IR, administration and human resource...agement team. ,, "One of my key objectives as ...
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawf...n (PSA) recurrence from the additional analysis of...te in a Phase III pivotal study of FIRMAGON® ...olide in prostate cancer patients during the first...received FIRMAGON 240/80 mg/month had a recurrence...
(Date:12/3/2009)... Allen Medical Systems, ...RC ), today announced the launch of its new Allen ...business website www.AllenAmatech.com . ,, ... identity and includes an online version of the ne...design specifications for the products. "We hope t...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 1Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 2Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 3AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 1AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 2AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 3Hartford grants increase support for geriatric social work training 49209 1Hartford grants increase support for geriatric social work training 49209 2Hartford grants increase support for geriatric social work training 49209 3
...ne in the Treatment of Patients with Relapsed/Ref...ented Tomorrow, Tuesday, June 3rd at 12:0...rmaceuticals,Inc. (Nasdaq: KERX ) today announced...ave been selected for both poster presentation and...al Oncology Meeting,currently taking place in Chic...
...erican Society of Clinical Oncology (ASCO),annual ...vival vs. external c...c.,(Nasdaq: IDMI ) today announced follow-up resu...t the product candidate was well tolerated, induce...sponses, and showed a,positive survival trend in H...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 4Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 5IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 2IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 3IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients 4
...fectively delivers clinically proven aminophylline...duction. Topical fat reduction with the aminophyll...on in fat and an increase in the firmness of the t...o the skin where it causes the body fat cells to s...
...ur is a non-invasive massage machine for skin, sca...m. Extraordinary results are achieved with our fam... vertical and parallel forces to produce effective...p tissue mobilization, kneading and compression, s...
Starvac SP2 Vacuum Cellulite Massage Therapy
Ritter 204 Manual Exam Table
Medicine Products: